- NCIt
- C4407
Loading cancer entity…
Loading cancer entity…
Clinical trials
46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07812259 | Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor(PAROCAINE) | recruiting | Early Phase 1 | 10 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT04704661 | Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial | active not recruiting | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Sep 4, 2026 | clinicaltrials |
| NCT00588770 | Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | active not recruiting | Phase 3 | 403 | National Cancer Institute (NCI)NIH | 3 | Aug 28, 2026 | clinicaltrials |
Data updated 20 days agoSource updated Sep 10, 2026source: clinicaltrials
| NCT04576091 | Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer | active not recruiting | Phase 1 | 7 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2026 | clinicaltrials |
| NCT01365169 | Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" | recruiting | N/A | 590 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT04895735 | MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | active not recruiting | Phase 2 | 45 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07620184 | Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery(SNaPs) | recruiting | N/A | 600 | Uppsala University HospitalOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06054178 | Identification of Nerves Using Fluorescein Sodium | completed | Phase 2 | 8 | Stanford UniversityOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT04870762 | Customized 3D Printed Oral Stents During Head and Neck Radiotherapy | recruiting | Phase 2 | 119 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07523373 | Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch | not yet recruiting | N/A | 20 | Sheba Medical CenterOTHER_GOV | 0 | Apr 13, 2026 | clinicaltrials |
| NCT05296109 | Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation | recruiting | N/A | 50 | Chinese University of Hong KongOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04613349 | FArial NErf MRI in the Preoperative Assessment of PArotide Tumors(NEFAPA) | recruiting | — | 88 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Jan 5, 2026 | clinicaltrials |
| NCT02628067 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | active not recruiting | Phase 2 | 1,609 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 22, 2025 | clinicaltrials |
| NCT07185542 | Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial. | completed | N/A | 120 | Al-Azhar UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07028437 | The Effect of Endoscopy-assisted Transoral Parotid Gland Tumor Excision Compared With Traditional Operation | completed | N/A | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04420689 | Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery | completed | Phase 1 / Phase 2 | 27 | Alume Biosciences, Inc.INDUSTRY | 1 | May 8, 2025 | clinicaltrials |
| NCT00405405 | Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT02538510 | Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 50 | University of WashingtonOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT06421649 | Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma(PRONTO) | not yet recruiting | N/A | 97 | The Christie NHS Foundation TrustOTHER | 0 | Aug 21, 2024 | clinicaltrials |
| NCT03146650 | Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer | unknown | Phase 2 | 25 | Northwestern UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03749460 | Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers | completed | Phase 1 / Phase 2 | 20 | University of WashingtonOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT03822728 | Intra-parotid Facial Nerve Imaging in Parotidectomy | completed | N/A | 270 | Samsung Medical CenterOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT05738395 | Symptoms of Frey's Syndrome | unknown | — | 20 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05505318 | Pattern and Surgical Treatment of Parotid Gland Neoplasms | unknown | — | 60 | Sohag UniversityOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05401370 | Role of Methylene Blue in Parotid Surgery | unknown | N/A | 20 | Assiut UniversityOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05152056 | MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors(Parotid) | completed | — | 133 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 10, 2021 | clinicaltrials |
| NCT04803032 | Trident Landmark as a Safe and Easy Method for Facial Nerve Trunk Identification During Superficial Parotidectomy | completed | N/A | 60 | Kafrelsheikh UniversityOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT01175980 | Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 2 | Aug 3, 2020 | clinicaltrials |
| NCT03950323 | Intra-parotid Facial Nerve Tractography(R-PO19053) | unknown | N/A | 40 | CHU de ReimsOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
| NCT04296266 | Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery | completed | Early Phase 1 | 10 | Stanford UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04104802 | Study of the Facial Nerve in MRI 3T in the Preoperative Assessment of Parotid Tumors(FACPAR) | withdrawn | — | 0 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Feb 25, 2020 | clinicaltrials |
| NCT01604772 | Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 1, 2019 | clinicaltrials |
| NCT03849482 | Multiparametric Magnetic Resonance Imaging Versus Fine Needle Aspiration Cytology for Parotid Gland Neoplasms | unknown | — | 100 | Davide Di SantoOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT00859937 | Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 2 | Apr 20, 2018 | clinicaltrials |
| NCT01256385 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy(MAESTRO HN) | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 2 | Mar 27, 2017 | clinicaltrials |
| NCT02294838 | Feasibility Study of MRI Imaging on Parotid Gland Stimulation(SPIT) | unknown | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02527226 | Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors | completed | N/A | 76 | Mayo ClinicOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01731379 | Optical Detection of Peripheral Nerve Bundles During Surgery(NerveSpect) | completed | — | 35 | Philips HealthcareINDUSTRY | 1 | Nov 3, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT01983176 | Retrospective Clinical Outcome of Parotid Tumor Surgery | completed | — | 767 | National Taiwan University HospitalOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT01414790 | The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome | completed | Phase 3 | 70 | West China HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00534612 | Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors | unknown | Early Phase 1 | 150 | National Institute of CancerologíaOTHER_GOV | 1 | Sep 26, 2007 | clinicaltrials |